Alliancebernstein L.P. lifted its position in LHC Group (NASDAQ:LHCG) by 254.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 67,104 shares of the health services provider’s stock after acquiring an additional 48,180 shares during the quarter. Alliancebernstein L.P. owned 0.38% of LHC Group worth $4,556,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Alps Advisors Inc. lifted its stake in LHC Group by 0.3% in the second quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock worth $641,000 after acquiring an additional 24 shares during the period. Federated Investors Inc. PA increased its position in LHC Group by 4.2% during the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after purchasing an additional 66 shares during the period. Arizona State Retirement System increased its position in LHC Group by 1.3% during the 2nd quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 100 shares during the period. Victory Capital Management Inc. increased its position in LHC Group by 0.3% during the 2nd quarter. Victory Capital Management Inc. now owns 48,920 shares of the health services provider’s stock valued at $3,321,000 after purchasing an additional 142 shares during the period. Finally, Texas Permanent School Fund increased its position in LHC Group by 1.4% during the 2nd quarter. Texas Permanent School Fund now owns 10,944 shares of the health services provider’s stock valued at $743,000 after purchasing an additional 153 shares during the period. Hedge funds and other institutional investors own 85.93% of the company’s stock.

Several brokerages have recently weighed in on LHCG. Bank of America Corporation started coverage on shares of LHC Group in a research report on Monday, August 21st. They issued a “buy” rating and a $76.00 price target for the company. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “hold” rating in a report on Thursday, July 6th. Royal Bank Of Canada reissued a “buy” rating on shares of LHC Group in a research note on Tuesday, June 13th. BidaskClub downgraded shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Finally, Robert W. Baird restated a “hold” rating and set a $63.00 target price on shares of LHC Group in a report on Tuesday, September 12th. Two equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $66.60.

WARNING: “Alliancebernstein L.P. Purchases 48,180 Shares of LHC Group (LHCG)” was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.watchlistnews.com/alliancebernstein-l-p-purchases-48180-shares-of-lhc-group-lhcg/1606863.html.

In other news, COO Donald Dwayne Stelly sold 2,650 shares of the firm’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the sale, the chief operating officer now directly owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 14.80% of the company’s stock.

Shares of LHC Group (NASDAQ:LHCG) opened at 71.18 on Wednesday. The stock has a market cap of $1.30 billion, a price-to-earnings ratio of 31.50 and a beta of 0.76. LHC Group has a one year low of $32.04 and a one year high of $73.85. The stock’s 50 day moving average price is $65.64 and its 200 day moving average price is $61.36.

LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.09. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The firm had revenue of $260.20 million for the quarter, compared to analysts’ expectations of $254.10 million. During the same quarter last year, the company earned $0.52 earnings per share. The firm’s revenue was up 15.1% compared to the same quarter last year. Analysts forecast that LHC Group will post $2.39 earnings per share for the current year.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with Analyst Ratings Network's FREE daily email newsletter.